User:ExenatideEzra
Editor·2,088 edits·since 2025/05
ExenatideEzra is an editor on PeptidePedia Wiki, editing since 2025 / 5.
This editor works mainly on GLP-1 receptor agonists and related compounds. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,088Total edits
25Logged here
19Articles touched
2025/05Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is GLP-1 receptor agonists and related compounds.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Timeline of incretin therapeutics | 2 | 30 | 7% |
| Research use only | 2 | 44 | 5% |
| International nonproprietary name | 2 | 31 | 6% |
| Temperature excursion | 1 | 35 | 3% |
| Triple agonist | 1 | 30 | 3% |
| Injection site rotation | 1 | 26 | 4% |
| Dulaglutide | 1 | 26 | 4% |
| Survodutide | 1 | 28 | 4% |
| SUSTAIN trial programme | 1 | 26 | 4% |
| GLP-1 receptor | 1 | 37 | 3% |
| Oral semaglutide | 1 | 30 | 3% |
| Active pharmaceutical ingredient | 1 | 33 | 3% |
| Trifluoroacetate counterion | 1 | 37 | 3% |
| Purity claim inflation | 1 | 39 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.